104 related articles for article (PubMed ID: 3607739)
1. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.
Jaques S; Tobes MC; Sisson JC
Cancer Res; 1987 Aug; 47(15):3920-8. PubMed ID: 3607739
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
Jaques S; Tobes MC; Sisson JC; Baker JA; Wieland DM
Mol Pharmacol; 1984 Nov; 26(3):539-46. PubMed ID: 6493209
[TBL] [Abstract][Full Text] [Related]
3. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.
Tobes MC; Jaques S; Wieland DM; Sisson JC
J Nucl Med; 1985 Aug; 26(8):897-907. PubMed ID: 3162008
[TBL] [Abstract][Full Text] [Related]
4. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
5. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Mastrangelo R
Cancer Res; 1993 Jan; 53(2):304-9. PubMed ID: 8417824
[TBL] [Abstract][Full Text] [Related]
6. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
7. Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
Yoffe JR; Borchardt RT
Mol Pharmacol; 1982 Mar; 21(2):368-73. PubMed ID: 7099140
[TBL] [Abstract][Full Text] [Related]
8. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
11. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.
Glowniak JV; Kilty JE; Amara SG; Hoffman BJ; Turner FE
J Nucl Med; 1993 Jul; 34(7):1140-6. PubMed ID: 8315492
[TBL] [Abstract][Full Text] [Related]
13. Sympathomimetic effects of MIBG: comparison with tyramine.
Graefe KH; Bossle F; Wölfel R; Burger A; Souladaki M; Bier D; Dutschka K; Farahati J; Bönisch H
J Nucl Med; 1999 Aug; 40(8):1342-51. PubMed ID: 10450687
[TBL] [Abstract][Full Text] [Related]
14. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Smets LA; Janssen M; Metwally E; Loesberg C
Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
[TBL] [Abstract][Full Text] [Related]
15. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
17. Sodium-independent transport of noradrenaline in mouse and rat astrocytes in primary culture.
Paterson IA; Hertz L
J Neurosci Res; 1989 May; 23(1):71-7. PubMed ID: 2746699
[TBL] [Abstract][Full Text] [Related]
18. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
19. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.
Sisson JC; Wieland DM; Sherman P; Mangner TJ; Tobes MC; Jacques S
J Nucl Med; 1987 Oct; 28(10):1620-4. PubMed ID: 3655914
[TBL] [Abstract][Full Text] [Related]
20. Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent.
Weng WL; Lazo JS; Gillis CN; Pitt BR
J Pharmacol Exp Ther; 1990 Oct; 255(1):59-65. PubMed ID: 2213571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]